Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$879M |
| 2 |
Bank of America
BAC
|
+$352M |
| 3 |
Intel
INTC
|
+$243M |
| 4 |
VanEck Gold Miners ETF
GDX
|
+$232M |
| 5 |
AB InBev
BUD
|
+$188M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.82B |
| 2 |
Amazon
AMZN
|
+$884M |
| 3 |
Air Products & Chemicals
APD
|
+$219M |
| 4 |
Mondelez International
MDLZ
|
+$198M |
| 5 |
WFT
Weatherford International plc
WFT
|
+$181M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 92.13% |
| 2 | Healthcare | 1.22% |
| 3 | Technology | 1.15% |
| 4 | Consumer Discretionary | 1.1% |
| 5 | Financials | 1.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3601
Ares Capital
ARCC
$14.3B
| $2.12M | ﹤0.01% |
121,791
-209,903
| -63% | -$3.63M |
|
|
INSY
3602
CALL
DELISTED
Insys Therapeutics, Inc.
INSY
| $2.12M | ﹤0.01% |
201,400
+74,300
| +58% | +$792K |
|
|
SWC
3603
CALL
DELISTED
Stillwater Mining Co
SWC
| $2.12M | ﹤0.01% |
122,500
-209,000
| -63% | -$3.57M |
|
|
RP
3604
PUT
DELISTED
RealPage, Inc.
RP
| $2.12M | ﹤0.01% |
60,600
+35,700
| +143% | +$1.17M |
|
3605
Stratasys
SSYS
$678M
| $2.11M | ﹤0.01% |
103,151
-174,545
| -63% | -$3.45M |
|
|
CEQP
3606
PUT
DELISTED
Crestwood Equity Partners LP
CEQP
| $2.11M | ﹤0.01% |
80,500
-115,300
| -59% | -$3.03M |
|
|
MSCC
3607
PUT
DELISTED
Microsemi Corp
MSCC
| $2.11M | ﹤0.01% |
41,000
-86,400
| -68% | -$4.64M |
|
3608
CALL
NNN REIT
NNN
$8.77B
| $2.11M | ﹤0.01% |
48,400
+13,200
| +38% | +$584K |
|
3609
CALL
Upbound Group
UPBD
$1.12B
| $2.11M | ﹤0.01% |
238,000
-32,500
| -12% | -$295K |
|
3610
iShares Core S&P Total US Stock Market ETF
ITOT
$97.4B
| $2.11M | ﹤0.01% |
39,048
-49,799
| -56% | -$2.66M |
|
3611
BWX Technologies
BWXT
$14B
| $2.11M | ﹤0.01% |
44,300
-83,601
| -65% | -$3.65M |
|
3612
CALL
O-I Glass
OI
$1.14B
| $2.11M | ﹤0.01% |
103,400
+42,400
| +70% | +$831K |
|
3613
MarineMax
HZO
$1.15B
| $2.1M | ﹤0.01% |
97,246
+69,072
| +245% | +$1.45M |
|
|
ZGNX
3614
CALL
DELISTED
Zogenix, Inc.
ZGNX
| $2.1M | ﹤0.01% |
193,900
-17,200
| -8% | -$174K |
|
3615
CALL
Chegg
CHGG
$93.7M
| $2.1M | ﹤0.01% |
249,200
+50,100
| +25% | +$386K |
|
3616
PUT
PTC Therapeutics
PTCT
$5.85B
| $2.1M | ﹤0.01% |
213,600
-168,000
| -44% | -$2.03M |
|
|
IBDH
3617
DELISTED
iShares iBonds Dec 2018 Term Corporate ETF
IBDH
| $2.1M | ﹤0.01% |
+83,497
| New | +$2.1M |
|
3618
CALL
Insmed
INSM
$25.9B
| $2.1M | ﹤0.01% |
120,000
-46,400
| -28% | -$716K |
|
3619
CALL
Brunswick
BC
$4.97B
| $2.1M | ﹤0.01% |
34,300
+15,700
| +84% | +$928K |
|
3620
CALL
iShares Russell 3000 ETF
IWV
$20.3B
| $2.1M | ﹤0.01% |
15,000
+1,500
| +11% | +$207K |
|
3621
PUT
Galicia Financial Group
GGAL
$6.78B
| $2.09M | ﹤0.01% |
55,300
+2,100
| +4% | +$70.5K |
|
3622
PUT
Broadridge
BR
$20.9B
| $2.09M | ﹤0.01% |
30,800
-3,100
| -9% | -$210K |
|
|
DBVT
3623
CALL
DBV Technologies
DBVT
$851M
| $2.09M | ﹤0.01% |
+5,940
| New | +$2.08M |
|
|
SNCR
3624
PUT
DELISTED
Synchronoss Technologies
SNCR
| $2.09M | ﹤0.01% |
9,522
+6,789
| +248% | +$1.98M |
|
3625
CALL
Extra Space Storage
EXR
$30.2B
| $2.09M | ﹤0.01% |
28,100
-11,200
| -28% | -$845K |
|
Similar funds
Jeff Yass's Q1 2017 Portfolio in Review
As of Q1 2017, Jeff Yass held 10,995 positions worth $198B, up 0.36% from $197B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Jeff Yass's Q1 2017 filing shows 1,488 new, 3,477 increased, 3,725 reduced and 2,170 closed positions. Its largest new stake was iShares MSCI EAFE ETF: 2,100,985 shares worth $131M. The largest sale was Apple, an estimated $1.82B.
By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, up from 91% a quarter earlier, followed by Healthcare and Technology.
- Jeff Yass's largest Q1 2017 buy was iShares MSCI EAFE ETF: 2,100,985 shares worth $131M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2017, an estimated $879M increase.
- Jeff Yass's biggest Q1 2017 reduction was Apple, cutting an estimated $1.82B.
- Jeff Yass fully exited Air Products & Chemicals in Q1 2017, selling an estimated $219M.
- Jeff Yass's ten largest holdings make up 22% of its $198B portfolio in Q1 2017.
- Jeff Yass opened 1,488 new positions and closed 2,170 in Q1 2017.
- Jeff Yass's portfolio value rose 0.36% quarter-over-quarter to $198B.
Based on Susquehanna International Group's 13F filing for Q1 2017, filed 15 May 2017.